CG MedTech Co.,Ltd. (KOSDAQ:056090)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,149.00
+6.00 (0.52%)
At close: Aug 11, 2026

CG MedTech Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
6,6036,50859.691,629-18,540-4,970
Depreciation & Amortization
2,6052,2641,6921,8532,2012,162
Loss (Gain) From Sale of Assets
-124.36-173.89-148.27-261.96-165.77-23.41
Asset Writedown & Restructuring Costs
173.18173.18-463.9-3,944
Loss (Gain) From Sale of Investments
1,0311,421258.52340.46-672.25-191.93
Stock-Based Compensation
--75.4259.629.54-
Provision & Write-off of Bad Debts
360.87299.78202.99-3,918126.82-107.26
Other Operating Activities
-3,057-3,625-2,226-1,36518,953619.7
Change in Accounts Receivable
-1,390-1,3491,4121,042-796.73328.9
Change in Inventory
-3,285-3,6531,546613.45152.11-645.64
Change in Accounts Payable
-773.96-1,082336.52281.19-1,733604.71
Change in Other Net Operating Assets
-3,2011,830-1,698-3,216-4,900-483.38
Operating Cash Flow
-1,0572,6131,511-2,478-5,3651,237
Operating Cash Flow Growth
-72.95%----42.45%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-12,013-11,479-773.97-1,590-819.5-862.16
Sale of Property, Plant & Equipment
128.29203.03333.04340.24295.59506.17
Cash Acquisitions
-6,958-8,485-3,084---1,597
Sale (Purchase) of Intangibles
-455.27-461.07-36-55.16-4.89-368.2
Investment in Securities
589.545,596-5,70956,461-52,696-3,205
Other Investing Activities
-775.91-777.51183.3918.12201.9204.99
Investing Cash Flow
-21,897-15,302-8,95055,025-52,255-4,651

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--36070081.31596.15
Long-Term Debt Issued
----70,10010,948
Total Debt Issued
10,500-36070070,18111,544
Short-Term Debt Repaid
--1,363-399.8--11,087-788.88
Long-Term Debt Repaid
--2,372-856.34-63,258-15,387-334.29
Total Debt Repaid
-3,206-3,735-1,256-63,258-26,475-1,123
Net Debt Issued (Repaid)
7,294-3,735-896.14-62,55843,70710,421
Issuance of Common Stock
--22,325-24,179-
Other Financing Activities
61.84--52.05-00-0
Financing Cash Flow
7,356-3,73521,377-62,55867,88610,421

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-48.32-67.7352.88160.63-102.77238.55
Net Cash Flow
-15,646-16,49114,290-9,85110,1637,245

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-13,069-8,866736.7-4,068-6,184375.08
Free Cash Flow Growth
------80.72%
Free Cash Flow Margin
-26.94%-18.77%2.13%-11.63%-15.02%0.99%
Free Cash Flow Per Share
-126.73-85.8612.34-51.58-92.958.43
Levered Free Cash Flow
-10,278-7,5454,127-460.1-9,617766.1
Unlevered Free Cash Flow
-10,168-7,4354,243-125.17-5,6681,575

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
471.71414.98207.98144.011,869352.3
Cash Income Tax Paid
72.48120.32-6.7-12.78305.7140.48
Change in Working Capital
-8,650-4,2531,596-1,279-7,277-195.4